FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3175432839> ?p ?o ?g. }

• W3175432839 endingPage "745" @default.
• W3175432839 startingPage "745" @default.
• W3175432839 abstract "This scoping review provides new evidence on the prevalence and patterns of global antimicrobial use in the treatment of COVID-19 patients; identifies the most commonly used antibiotics and clinical scenarios associated with antibiotic prescribing in the first phase of the pandemic; and explores the impact of documented antibiotic prescribing on treatment outcomes in COVID-19 patients. The review complies with PRISMA guidelines for Scoping Reviews and the protocol is registered with the Open Science Framework. In the first six months of the pandemic, there was a similar mean antibiotic prescribing rate between patients with severe or critical illness (75.4%) and patients with mild or moderate illness (75.1%). The proportion of patients prescribed antibiotics without clinical justification was 51.5% vs. 41.9% for patients with mild or moderate illness and those with severe or critical illness. Comparison of patients who were provided antibiotics with a clinical justification with those who were given antibiotics without clinical justification showed lower mortality rates (9.5% vs. 13.1%), higher discharge rates (80.9% vs. 69.3%), and shorter length of hospital stay (9.3 days vs. 12.2 days). In the first 6 months of the pandemic, antibiotics were prescribed for COVID-19 patients regardless of severity of illness. A large proportion of antibiotic prescribing for mild and moderate COVID-19 patients did not have clinical evidence of a bacterial co-infection. Antibiotics may not be beneficial to COVID-19 patients without clinical evidence of a bacterial co-infection." @default.
• W3175432839 created "2021-07-05" @default.
• W3175432839 creator A5006682337 @default.
• W3175432839 creator A5012550817 @default.
• W3175432839 creator A5019727393 @default.
• W3175432839 creator A5021168220 @default.
• W3175432839 creator A5033589624 @default.
• W3175432839 creator A5066026957 @default.
• W3175432839 date "2021-06-19" @default.
• W3175432839 modified "2023-10-03" @default.
• W3175432839 title "Antimicrobial Use in COVID-19 Patients in the First Phase of the SARS-CoV-2 Pandemic: A Scoping Review" @default.
• W3175432839 cites W1816338487 @default.
• W3175432839 cites W1995615618 @default.
• W3175432839 cites W2078607672 @default.
• W3175432839 cites W2107334235 @default.
• W3175432839 cites W2180752973 @default.
• W3175432839 cites W2341045092 @default.
• W3175432839 cites W2891378911 @default.
• W3175432839 cites W2895079403 @default.
• W3175432839 cites W3004824173 @default.
• W3175432839 cites W3012379316 @default.
• W3175432839 cites W3014003872 @default.
• W3175432839 cites W3018949648 @default.
• W3175432839 cites W3020512604 @default.
• W3175432839 cites W3023977941 @default.
• W3175432839 cites W3024236281 @default.
• W3175432839 cites W3024447255 @default.
• W3175432839 cites W3025951714 @default.
• W3175432839 cites W3029242200 @default.
• W3175432839 cites W3032978545 @default.
• W3175432839 cites W3035353028 @default.
• W3175432839 cites W3039269339 @default.
• W3175432839 cites W3043975336 @default.
• W3175432839 cites W3046635636 @default.
• W3175432839 cites W3048234417 @default.
• W3175432839 cites W3080414449 @default.
• W3175432839 cites W3081368778 @default.
• W3175432839 cites W3089688465 @default.
• W3175432839 cites W3091347349 @default.
• W3175432839 cites W3097149523 @default.
• W3175432839 cites W3165656738 @default.
• W3175432839 cites W4205090950 @default.
• W3175432839 doi "https://doi.org/10.3390/antibiotics10060745" @default.
• W3175432839 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8235357" @default.
• W3175432839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34205440" @default.
• W3175432839 hasPublicationYear "2021" @default.
• W3175432839 type Work @default.
• W3175432839 sameAs 3175432839 @default.
• W3175432839 citedByCount "33" @default.
• W3175432839 countsByYear W31754328392021 @default.
• W3175432839 countsByYear W31754328392022 @default.
• W3175432839 countsByYear W31754328392023 @default.
• W3175432839 crossrefType "journal-article" @default.
• W3175432839 hasAuthorship W3175432839A5006682337 @default.
• W3175432839 hasAuthorship W3175432839A5012550817 @default.
• W3175432839 hasAuthorship W3175432839A5019727393 @default.
• W3175432839 hasAuthorship W3175432839A5021168220 @default.
• W3175432839 hasAuthorship W3175432839A5033589624 @default.
• W3175432839 hasAuthorship W3175432839A5066026957 @default.
• W3175432839 hasBestOaLocation W31754328391 @default.
• W3175432839 hasConcept C126322002 @default.
• W3175432839 hasConcept C177713679 @default.
• W3175432839 hasConcept C187212893 @default.
• W3175432839 hasConcept C2779134260 @default.
• W3175432839 hasConcept C3008058167 @default.
• W3175432839 hasConcept C4937899 @default.
• W3175432839 hasConcept C501593827 @default.
• W3175432839 hasConcept C524204448 @default.
• W3175432839 hasConcept C71924100 @default.
• W3175432839 hasConcept C86803240 @default.
• W3175432839 hasConcept C89423630 @default.
• W3175432839 hasConcept C89623803 @default.
• W3175432839 hasConceptScore W3175432839C126322002 @default.
• W3175432839 hasConceptScore W3175432839C177713679 @default.
• W3175432839 hasConceptScore W3175432839C187212893 @default.
• W3175432839 hasConceptScore W3175432839C2779134260 @default.
• W3175432839 hasConceptScore W3175432839C3008058167 @default.
• W3175432839 hasConceptScore W3175432839C4937899 @default.
• W3175432839 hasConceptScore W3175432839C501593827 @default.
• W3175432839 hasConceptScore W3175432839C524204448 @default.
• W3175432839 hasConceptScore W3175432839C71924100 @default.
• W3175432839 hasConceptScore W3175432839C86803240 @default.
• W3175432839 hasConceptScore W3175432839C89423630 @default.
• W3175432839 hasConceptScore W3175432839C89623803 @default.
• W3175432839 hasFunder F4320334626 @default.
• W3175432839 hasIssue "6" @default.
• W3175432839 hasLocation W31754328391 @default.
• W3175432839 hasLocation W31754328392 @default.
• W3175432839 hasLocation W31754328393 @default.
• W3175432839 hasLocation W31754328394 @default.
• W3175432839 hasLocation W31754328395 @default.
• W3175432839 hasLocation W31754328396 @default.
• W3175432839 hasLocation W31754328397 @default.
• W3175432839 hasOpenAccess W3175432839 @default.
• W3175432839 hasPrimaryLocation W31754328391 @default.
• W3175432839 hasRelatedWork W3103289217 @default.
• W3175432839 hasRelatedWork W3106370311 @default.
• W3175432839 hasRelatedWork W3108360120 @default.

• next